Patent · US Revoked

Systems and methods for treatments of an eye with a photosensitizer

US11154618B2 · kind B2 · utility

0Cited by
123References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 21, 2016
Grant dateOct 26, 2021
Priority date
Expiry dateSep 5, 2036

Classification

  • Technology area (CPC —)General

Abstract

A formulation for an eye treatment includes a photosensitizer and a permeability enhancing composition. The permeability enhancing composition includes one or more permeability enhancers. The permeability enhancing composition has a hydrophilic and lipophilic balance increases a permeability of an area of the eye for the photosensitizer. The hydrophilic and lipophilic balance can be characterized by a Hydrophile-Lipophile Balance (HLB) number. For example, the area of the eye may include a corneal epithelium, the photosensitizer may include riboflavin, and the permeability enhancing composition may have a corresponding HLB number between approximately 12.6 and approximately 14.6.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.